Sechenov School
Home › Pharmacology › Anticoagulants

Anticoagulants

*Anticoagulantia*

For medical students2 min readUpdated 2026-10-10

Anticoagulants are pharmacological agents that reduce blood coagulability. They exert their effects through two main pathways: either by directly inhibiting already activated clotting factors in the systemic circulation, or by disrupting their synthesis in hepatic tissues.

Main goalReduction of blood coagulability by targeting coagulation factors.
Site of actionLiver (for indirect) and systemic circulation (for direct anticoagulants).
Heparin targetsAlready activated clotting factors: IXa, Xa, and IIa (thrombin).
Warfarin targetsDisruption of inactive factor synthesis: VII, IX, X, and II (prothrombin).
Factor proteolysisRecombinant protein C acts via proteolysis of factors VIIIa and Va.

Mechanism of Action: Two Pathways of Reducing Coagulability

All agents that reduce blood coagulability share a common therapeutic principle: they prevent thrombus formation. However, they achieve this goal through entirely different mechanisms. Broadly, they can be divided into two main categories depending on their site of action and the state of the coagulation factors they target.

The first pathway operates directly within the systemic circulation. Direct anticoagulants (with heparin as the classic prototype) interact with clotting factors directly in the bloodstream. Crucially, these drugs inhibit already activated factors. In other words, enzymes that have already triggered the coagulation cascade are blocked and lose their activity. The primary pharmacological targets for this group include activated factors IXa, Xa, and factor IIa, better known as thrombin.

The second pathway involves interfering with the synthesis of the factors themselves. Indirect anticoagulants (such as warfarin) have no effect on proteins already circulating in the blood. Their site of action is the liver, where they disrupt the synthesis of new coagulation factors. As a result, fully functional inactive precursors—factors VII, IX, X, and factor II (prothrombin)—cease to be released into the blood. Their plasma stores gradually become depleted, leading to a drop in coagulability.

Detailed Classification of Direct Anticoagulants

The direct-acting drug group is quite diverse. It comprises several subclasses, each with a strict molecular target and specific chemical structure.

  1. Direct thrombin (Factor IIa) inhibitors. These agents specifically bind to thrombin and remove it from the coagulation cascade. This subgroup includes hirudin derivatives such as lepirudin and bivalirudin, as well as the modern oral agent dabigatran.
  2. Direct factor Xa inhibitors. These agents block activated factor X without directly affecting thrombin. A prominent and well-known example of this narrow subgroup is rivaroxaban.
  3. Factor Va and VIIIa inhibitors. The mechanism of this group differs from the previous ones: they do not simply bind to factors, but induce their proteolysis (destruction). This category includes drotrecogin alfa, a recombinant activated protein C.

Chemical Classes of Indirect Anticoagulants

Because all indirect anticoagulants share a single site of action (suppressing coagulation factor synthesis in hepatic tissue), they are traditionally classified by their chemical structure rather than their molecular targets. Two primary chemical classes are recognized:

Mnemonic

Direct anticoagulants work in the blood on activated factors (their designations contain the letter "a": IXa, Xa, IIa). Indirect agents act via the liver, disrupting the synthesis of baseline factors (without the letter "a": VII, IX, X, II).

Frequently asked questions

Which drugs are direct thrombin (factor IIa) inhibitors?

Direct thrombin (factor IIa) inhibitors include hirudin preparations and dabigatran.

  • Hirudin derivatives — include lepirudin (recombinant hirudin) and bivalirudin. Lepirudin is administered intravenously, primarily for heparin-induced thrombocytopenia.
  • Dabigatran — a direct inhibitor used as a prodrug (dabigatran etexilate) that binds directly to the catalytic active site of the enzyme.
Which drugs are direct factor Xa inhibitors?

Direct factor Xa inhibitors include rivaroxaban, apixaban, and edoxaban.

  • Rivaroxaban — blocks factor Xa both in free form and within the prothrombinase complex; administered once daily.
  • Apixaban — a selective inhibitor administered twice daily.
  • Edoxaban — administered at a dose of 60 mg once daily (with potential dose reduction to 30 mg in specific populations).
What is the specific antidote for heparin overdose?

Protamine sulfate is the specific antidote used for heparin overdose.

  • Protamine sulfate — binds to the anionic centers of heparin, forming an insoluble complex and chemically neutralizing its anticoagulant effect.

It is administered via slow intravenous injection during severe bleeding. The calculated dose is 1 mg of protamine sulfate per 100 units of heparin sodium. This antidote is less effective in overdoses involving low-molecular-weight heparins.

Which laboratory parameter is used to monitor warfarin therapy?

Warfarin therapy is monitored using the INR (International Normalized Ratio).

  • INR 2.0–2.5 — target range for standard treatment.
  • INR 3.0–4.0 — target range for patients with mechanical heart valves.

The initial test is performed 24–48 hours after starting therapy. When transitioning a patient from low-molecular-weight heparins to warfarin, overlapping administration for the first 4–5 days is required under INR monitoring.

What specific adverse effects does heparin cause?

Unfractionated heparin therapy can cause several specific adverse effects.

  • Heparin-induced thrombocytopenia (HIT) — can be early (benign) or late immune-mediated, which is accompanied by paradoxical thrombosis.
  • Osteoporosis — risk increases with prolonged use (more than 3 months).
  • Hyperkalemia — a rare complication associated with suppression of adrenal aldosterone synthesis.

Reversible alopecia, elevated liver transaminases, and allergic reactions, including skin rash and arthralgia, are also possible.

What are the absolute contraindications to anticoagulant therapy?

Long-term anticoagulant therapy is contraindicated in the following conditions:

  • Major bleeding — involving the gastrointestinal, pulmonary, or urogenital systems due to an irreversible cause.
  • Spontaneous intracranial or intraspinal bleeding — due to an irreversible cause.
  • Severe bleeding — associated with recurrent trauma where the underlying cause cannot be managed.

For the prevention of thrombosis and ischemic stroke, a documented threat of hemorrhagic stroke serves as a contraindication.

What is the general principle of action of all anticoagulants?

The general principle of these pharmacological agents is to reduce blood coagulability. This is achieved either by inhibiting already activated coagulation factors directly within the bloodstream or by impairing the synthesis of new factors in the liver.

Which specific clotting factors does heparin block?

Heparin is a classic direct anticoagulant. Its pharmacological targets are factors that have already transitioned into an active state, specifically factors IXa, Xa, and IIa (thrombin).

How does warfarin work, and which factors does it affect?

Warfarin belongs to the indirect anticoagulants (coumarin derivatives). It does not act in the bloodstream; instead, it acts in the liver, where it inhibits the synthesis of factors VII, IX, X, and II (prothrombin).

What is drotrecogin alfa and what is its mechanism?

Drotrecogin alfa is a recombinant activated protein C. It acts as a direct anticoagulant by promoting the proteolysis (cleavage) of activated factors Va and VIIIa.

Go deeper

More topics in Pharmacology

Pulmonary Surfactants: Pharmacology and Clinical UseAntipseudomonal PenicillinsBone Marrow Preparations: Myelopid PharmacologyHerbal AntisepticsNaphazoline: Pharmacology, Mechanism and Clinical UseParacetamolAtenololIrbesartanNeostigmineRibavirinSelective Norepinephrine Reuptake InhibitorsNon-CYP Enzymes and Genetic PolymorphismPharmacology →